
Top 10 Cancer Research News Stories of 2018
Top 10 Cancer Research News Stories of 2018
Σκοπός του Ιntelligence-pharma είναι να σας ενημερώνει για τις τελευταίες τάσεις και αναλύσεις σχετικά με τον ταχέως μεταβαλλόμενο κόσμο του φαρμάκου.
Top 10 Cancer Research News Stories of 2018
Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials
Merck takes a back seat on CAR-T, handing assets to Intrexon
Gilead deepens immuno-oncology push with Agenus deal
Astellas Acquires Collaboration Partner Potenza, Adding Cancer Immunotherapy Programs
Roche wins key cancer drug approval, but taking on Merck remains a challenge
Roche’s Tecentriq wins key lung cancer approval. Its prize? A showdown with formidable Merck
Can Immunotherapy Offer New Hope for Parkinson’s Sufferers?
Miracle Drugs Don’t Always Work— A Rare but Lethal Case of an Immuno-Oncology Backfire
Deep Dive: Immunovative Therapies’ Next-Generation Cancer Vaccine Could Change the Game
Nektar Therapeutics Presents New Clinical and Preclinical Data for its Immuno-Oncology Pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Cancer Immunotherapy Phase I on Hold After Patient Death
James Allison Has Unfinished Business with Cancer
New Tool Added to the Cancer Immunotherapy Toolbox
Using Therapeutic Antibodies Against Alzheimer’s Disease
Why Does Immunotherapy Cost So Much?